title: Opinion paper: Quo vadis - EFSA?
abstract: In times when human life and quality of life remain threatened by infectious diseases, increasing microbial resistance and a diminished armamentarium of treatments, you might think that the European Commission would urgently seek and encourage alternative approaches. On the contrary, the European Food Safety Authority (EFSA) has created a panel that has ignored good science, over-ridden peer-reviewed medical studies, and seems intent on breaking the back of a validated approach to infectious disease management, namely probiotics. The recent rejection of a simple and quite bland claim related to vaginal health emphasises the travesty of this bureaucracy. Herein, the science fights back and counters the critique of EFSA.
authors: Lawson Health Research Institute, Canadian Research & Development Centre for Probiotics, London N6A 4V2 Ontario, Canada. gregor@uwo.ca
authors: G
authors: G
authors: Reid
mesh_terms: D003257:Consumer Product Safety; D017277:Drug Approval / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D005060:Europe; D035082:Federal Government; D005260:Female; D006801:Humans; D007778:Lactobacillus / Q000502:physiology*; D019936:Probiotics / Q000627:therapeutic use*; D014623:Vaginal Diseases / Q000188:drug therapy* / Q000382:microbiology